The first successful desensitization protocol in exenatide allergy: a case report
Glucagon-like peptide-1 (GLP-1) receptor agonists are important treatment options in obese patients with type 2 diabetes. To date, few immediate allergic reactions due to GLP-1 receptor agonists were reported....
Source: Allergy, Asthma and Clinical Immunology - Category: Allergy & Immunology Authors: Osman Ozan Ye ğit, Göktuğ Sarıbeyliler, Pelin Karadağ, Semra Demir, Nurdan Gül, Derya Ünal and Aslı Gelincik Akkor Tags: Case report Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Byetta | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Obesity